Twist Bioscience Addresses Misleading Short-Seller Report

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today addressed a misleading short-seller report issued by Scorpion Capital. Twist believes that the short-seller report issued by Scorpion Capital is highly misleading, with...

Click to view original post